Publications by authors named "Bart de Goeij"


Comparison of CD38 antibodies in vitro and ex vivo mechanisms of action in multiple myeloma.

Haematologica 2021 Jan 14. Epub 2021 Jan 14.

Department of Hematology, Amsterdam University Medical Center, Vrije Universiteit Amsterdam, Cancer Center Amsterdam, Amsterdam.

View Article and Find Full Text PDF
January 2021

New developments for antibody-drug conjugate-based therapeutic approaches.

Curr Opin Immunol 2016 06 7;40:14-23. Epub 2016 Mar 7.

ImmunoGen, Inc., 830 Winter Street, Waltham, MA 02451, United States.

View Article and Find Full Text PDF
June 2016

High turnover of tissue factor enables efficient intracellular delivery of antibody-drug conjugates.

Mol Cancer Ther 2015 May 27;14(5):1130-40. Epub 2015 Feb 27.

Genmab, Utrecht, the Netherlands. Department of Cancer and Inflammation Research, Institute of Molecular Medicine, University of Southern Denmark, Odense, Denmark. Department of Immunohematology and Blood Transfusion, Leiden University Medical Center, Leiden, the Netherlands.

View Article and Find Full Text PDF
May 2015

An antibody-drug conjugate that targets tissue factor exhibits potent therapeutic activity against a broad range of solid tumors.

Cancer Res 2014 Feb 26;74(4):1214-26. Epub 2013 Dec 26.

Authors' Affiliations: Genmab, Utrecht, the Netherlands; Genmab, Copenhagen, Denmark; and Center for Thrombosis Research, Florida Hospital, Orlando, Florida.

View Article and Find Full Text PDF
February 2014